Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 ビュー
• 06/28/23
0
0
埋め込む
administrator
加入者
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント